Squarepoint
ALDR

Squarepoint’s Alder Biopharmaceuticals ALDR Stock Holding History

Squarepoint’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,017
Closed -$566K – 2982
2019
Q3 		$566K Buy
+30,017
New +$343K 0.01% 1552
2019
Q2 		– Sell
-25,596
Closed -$349K – 2812
2019
Q1 		$349K Sell
25,596
-13,357
-34% -$173K ﹤0.01% 1682
2018
Q4 		$399K Sell
38,953
-5,782
-13% -$74K ﹤0.01% 1372
2018
Q3 		$745K Buy
44,735
+20,780
+87% +$376K 0.01% 1127
2018
Q2 		$378K Sell
23,955
-131,756
-85% -$2M 0.01% 1286
2018
Q1 		$1.98M Buy
155,711
+124,353
+397% +$1.8M 0.03% 580
2017
Q4 		$359K Buy
+31,358
New +$350K 0.01% 1393
2016
Q1 		– Sell
-13,900
Closed -$459K – 1577
2015
Q4 		$459K Buy
+13,900
New +$470K 0.05% 581
2015
Q3 		– Sell
-6,300
Closed -$334K – 641
2015
Q2 		$334K Buy
+6,300
New +$229K 0.11% 270

Squarepoint's ALDR Position: Q4 2019 in Review

Squarepoint sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 30,017 shares — an estimated $566K sold.

Squarepoint first reported a position in ALDR in Q2 2015 and held it in 9 quarters. The position peaked at $1.98M in Q1 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Squarepoint reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Squarepoint sold 30,017 Alder Biopharmaceuticals shares in Q4 2019, an estimated $566K.
  • Squarepoint first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 9 quarters.
  • Squarepoint's Alder Biopharmaceuticals position peaked at $1.98M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Squarepoint's 13F filing for Q4 2019, filed 14 Feb 2020.